-
1
-
-
77955659229
-
Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: A single center retrospective study
-
Atta EH, Dias DS, Marra VL et al (2010) Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single center retrospective study. Ann Hematol 89:851-859
-
(2010)
Ann Hematol
, vol.89
, pp. 851-859
-
-
Atta, E.H.1
Dias, D.S.2
Marra, V.L.3
-
2
-
-
0028913625
-
Antilymphocyte globulin, cyclosporin and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): A pilot study of the EBMT SAA Working Party
-
Bacigalupo A, Broccia G, Corda G et al (1995) Antilymphocyte globulin, cyclosporin and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 85:1348-1353
-
(1995)
Blood
, vol.85
, pp. 1348-1353
-
-
Bacigalupo, A.1
Broccia, G.2
Corda, G.3
-
3
-
-
78449251007
-
The use of anti-human T lymphocyte porcine immunoglobulin and cyclosporine A to treat patients with acquired severe aplastic anemia
-
Bing H, Siyi Y, Weg Z et al (2010) The use of anti-human T lymphocyte porcine immunoglobulin and cyclosporine A to treat patients with acquired severe aplastic anemia. Acta Haematol 124:245-250
-
(2010)
Acta Haematol
, vol.124
, pp. 245-250
-
-
Bing, H.1
Siyi, Y.2
Weg, Z.3
-
4
-
-
33750473058
-
Rituximab therapy of severe aplastic anemia induced by fludarabine and cyclophosphamide in a patient affected by B-cell chronic lymphocytic leukemia [12]
-
DOI 10.1080/10428190600709630, PII R12Q0078222L787N
-
Castiglione MG, Scatena P, Pandolfo C et al (2006) Rituximab therapy of severe aplastic anemia induced by fludarabine and cyclophosphamide in a patient affected by B-cell chronic lymphocytic leukemia. Leuk Lymphoma 47:1985-1986 (Pubitemid 44649793)
-
(2006)
Leukemia and Lymphoma
, vol.47
, Issue.9
, pp. 1985-1986
-
-
Castiglioni, M.G.1
Scatena, P.2
Pandolfo, C.3
Mechelli, S.4
Bianchi, M.5
-
5
-
-
0020679706
-
Antithymocyte globulin treatment in patients with aplastic anemia. A prospective randomized trial
-
Champlin R, Ho W, Gale RP (1983) Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med 308:113-118 (Pubitemid 13224115)
-
(1983)
New England Journal of Medicine
, vol.308
, Issue.3
, pp. 113-118
-
-
Champlin, R.1
Ho, W.2
Gale, R.P.3
-
6
-
-
0024513594
-
Low doses of high-potency antithymocyte globulin (ATG) in sever aplastic anemia: Experience with the Mexican ATG
-
Delgado-Lamas JL, López-Karpovitch X, Marín-López A et al (1989) Low-doses of high-potency antithymocyte globulin (ATG) in severe aplastic anemia: experience with the Mexican ATG. Acta Haematol 81:70-74 (Pubitemid 19099979)
-
(1989)
Acta Haematologica
, vol.81
, Issue.2
, pp. 70-74
-
-
Delgado-Lamas, J.L.1
Lopez-Karpovitch, X.2
Marin-Lopez, A.3
Romero-Garcia, F.4
Ruiz-Arguelles, G.J.5
Ruiz-Gonzalez, D.S.6
Taboada, C.7
Vazquez-Villegas, V.8
Zarzosa, M.E.9
-
7
-
-
0032734041
-
Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy
-
DOI 10.1046/j.1365-2141.1999.01693.x
-
Di Bona E, Rodeghiero F, Bruno B et al (1999) Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Br J Haematol 107:330-334 (Pubitemid 29530219)
-
(1999)
British Journal of Haematology
, vol.107
, Issue.2
, pp. 330-334
-
-
Di, B.E.1
Rodeghiero, F.2
Bruno, B.3
Gabbas, A.4
Foa, P.5
Locasciulli, A.6
Rosanelli, C.7
Camba, L.8
Saracco, P.9
Lippi, A.10
Iori, A.P.11
Porta, F.12
De Rossi, V.13
Comotti, B.14
Iacopino, P.15
Dufour, C.16
Bacigalupo, A.17
-
8
-
-
73149090804
-
Changes in cytokine profile pre and post immunosuppression in acquired aplastic anemia
-
Dufour C, Ferretti E, Bagnasco F et al (2009) Changes in cytokine profile pre and post immunosuppression in acquired aplastic anemia. Haematologica 94:1743-1747
-
(2009)
Haematologica
, vol.94
, pp. 1743-1747
-
-
Dufour, C.1
Ferretti, E.2
Bagnasco, F.3
-
9
-
-
0025865140
-
Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine
-
The German Aplastic Anemia Study Group
-
Frickhofen N, Kaltwasser JP, Schrezenmeier H et al (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med 324:1297-1304
-
(1991)
N Engl J Med
, vol.324
, pp. 1297-1304
-
-
Frickhofen, N.1
Kaltwasser, J.P.2
Schrezenmeier, H.3
-
10
-
-
0037441586
-
Antithymocyte globulin with or without cyclosporin A: 11-Year follow-up of a randomized trial comparing treatments of aplastic anemia
-
DOI 10.1182/blood-2002-04-1134
-
Frickhofen N, Heimpel H, Kaltwasser JP et al (2003) Antithymocyte globulin with or without cyclosporine A: 11-year follow-up of a randomised trial comparing treatments of aplastic anemia. Blood 101:1236-1242 (Pubitemid 36182490)
-
(2003)
Blood
, vol.101
, Issue.4
, pp. 1236-1242
-
-
Frickhofen, N.1
Heimpel, H.2
Kaltwasser, J.P.3
Schrezenmeier, H.4
-
11
-
-
73449106771
-
Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia
-
Fuijiwara S, Miyake H, Nosaka K (2009) Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia. Int J Hematol 90:471-475
-
(2009)
Int J Hematol
, vol.90
, pp. 471-475
-
-
Fuijiwara, S.1
Miyake, H.2
Nosaka, K.3
-
12
-
-
33644505809
-
Allografting in patients with severe aplastic anemia using peripheral blood stem cells and a fludarabine-based conditoning regimen: The Mexican Experience
-
Gómez-Almaguer D, Vela-Ojeda J, Jaime-Pérez JC et al (2006) Allografting in patients with severe aplastic anemia using peripheral blood stem cells and a fludarabine-based conditoning regimen: the Mexican Experience. Am J Hematol 81:157-161
-
(2006)
Am J Hematol
, vol.81
, pp. 157-161
-
-
Gómez-Almaguer, D.1
Vela-Ojeda, J.2
Jaime-Pérez, J.C.3
-
14
-
-
77949321839
-
Subcutaneous alemtuzumab plus cyclosporine for the treatment of aplastic anemia
-
Gómez-Almaguer D, Jaime-Perez JC, Garza-Rodriguez V et al (2010a) Subcutaneous alemtuzumab plus cyclosporine for the treatment of aplastic anemia. Ann Hematol 89:299-303
-
(2010)
Ann Hematol
, vol.89
, pp. 299-303
-
-
Gómez-Almaguer, D.1
Jaime-Perez, J.C.2
Garza-Rodriguez, V.3
-
15
-
-
78649690155
-
Low dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoinmune cytopenias
-
Gómez-Almaguer D, Solano-Genesta M, Tarín-Arzaga L et al (2010b) Low dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoinmune cytopenias. Blood 116:4783-4785
-
(2010)
Blood
, vol.116
, pp. 4783-4785
-
-
Gómez-Almaguer, D.1
Solano-Genesta, M.2
Tarín-Arzaga, L.3
-
16
-
-
15544377256
-
Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning
-
DOI 10.1038/sj.bmt.1704799
-
Grupta V, Ball SE, Sage D et al (2005) Marrow transplants from matched unrelated donors for aplastic anemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Transplant 35:467-471 (Pubitemid 40403349)
-
(2005)
Bone Marrow Transplantation
, vol.35
, Issue.5
, pp. 467-471
-
-
Gupta, V.1
Ball, S.E.2
Sage, D.3
Ortin, M.4
Freires, M.5
Gordon-Smith, E.C.6
Marsh, J.C.W.7
-
17
-
-
28544432438
-
Aplastic anemia successfully treated with rituximab
-
DOI 10.1002/ajh.20428
-
Hansen PB, Lauritzen AM (2005) Aplastic anemia successfully treated with rituximab. Am J Hematol 80:292-294 (Pubitemid 41746177)
-
(2005)
American Journal of Hematology
, vol.80
, Issue.4
, pp. 292-294
-
-
Hansen, P.B.1
Lauritzen, A.M.F.2
-
20
-
-
79958021197
-
Relapse of aplastic anemia in children after immunossuppresive therapy: A report from the Japan Childhood Aplastic Anemia Study Group
-
Kamio T, Ito E, Ohara A et al (2011) Relapse of aplastic anemia in children after immunossuppresive therapy: a report from the Japan Childhood Aplastic Anemia Study Group. Haematologica 96:814-819
-
(2011)
Haematologica
, vol.96
, pp. 814-819
-
-
Kamio, T.1
Ito, E.2
Ohara, A.3
-
21
-
-
56949093138
-
A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome
-
Kim H, Min YJ, Baeck JH et al (2009) A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome. Leuk Res 33:222-231
-
(2009)
Leuk Res
, vol.33
, pp. 222-231
-
-
Kim, H.1
Min, Y.J.2
Baeck, J.H.3
-
22
-
-
80955177543
-
The Third Consensus Conference on the treatment of aplastic anemia
-
Kojima S, Nakao S, Young N et al (2011) The Third Consensus Conference on the treatment of aplastic anemia. Int J Hematol 93:832-837
-
(2011)
Int J Hematol
, vol.93
, pp. 832-837
-
-
Kojima, S.1
Nakao, S.2
Young, N.3
-
23
-
-
0034668824
-
A critical role for B cells in the development of memory CD4 cells
-
Linton PJ, Harbertson J, Bradley LM (2000) A critical role for B cells in the development of memory CD4 cells. J Immunol 165:5558-5565
-
(2000)
J Immunol
, vol.165
, pp. 5558-5565
-
-
Linton, P.J.1
Harbertson, J.2
Bradley, L.M.3
-
25
-
-
0029048258
-
Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia
-
Maciejewski JP, Selleri C, Sato T et al (1995) Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anaemia. Br J Haematol 91:245-252
-
(1995)
Br J Haematol
, vol.91
, pp. 245-252
-
-
Maciejewski, J.P.1
Selleri, C.2
Sato, T.3
-
26
-
-
0242579305
-
Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia
-
DOI 10.1182/blood-2003-04-1032
-
Maciejewski JP, Sloand EM, Nuñez O et al (2003) Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia. Blood 102:3584-3586 (Pubitemid 37409374)
-
(2003)
Blood
, vol.102
, Issue.10
, pp. 3584-3586
-
-
Maciejewski, J.P.1
Sloand, E.M.2
Nunez, O.3
Boss, C.4
Young, N.S.5
-
27
-
-
10744219545
-
Guidelines for the diagnosis and management of acquired aplastic anaemia
-
DOI 10.1046/j.1365-2141.2003.04721.x
-
Marsh JC, Ball SE, Darbyshire P et al (2003) Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol 123:782-801 (Pubitemid 37533290)
-
(2003)
British Journal of Haematology
, vol.123
, Issue.5
, pp. 782-801
-
-
Marsh, J.C.W.1
Ball, S.E.2
Darbyshire, P.3
Gordon-Smith, E.C.4
Keidan, A.J.5
Martin, A.6
McCann, S.R.7
Mercieca, J.8
Oscier, D.9
Roques, A.W.W.10
Yin, J.A.L.11
-
28
-
-
0036381344
-
Seeing the good and bad in aplastic anemia: Is autoimmunity in AA dysregulated or antineoplastic?
-
Nissen C, Schubert J (2002) Seeing the good and bad in aplastic anemia: is autoimmunity in AA dysregulated or antineoplastic? Hematol J 3:169-175
-
(2002)
Hematol J
, vol.3
, pp. 169-175
-
-
Nissen, C.1
Schubert, J.2
-
29
-
-
62949229281
-
Immunosuppressive treatment for aplastic anemia: Are we hitting the ceiling?
-
Passweg J, Tichelli A (2009) Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling? Haematologica 94: 310-312
-
(2009)
Haematologica
, vol.94
, pp. 310-312
-
-
Passweg, J.1
Tichelli, A.2
-
30
-
-
78549294158
-
Autoantibodies specific to hnRNP K: A new diagnostic marker for immune pathophysiology in aplastic anemia
-
Qi Z, Takamatsu H, Espinoza JL et al (2010) Autoantibodies specific to hnRNP K: a new diagnostic marker for immune pathophysiology in aplastic anemia. Ann Hematol 89:1255-1263
-
(2010)
Ann Hematol
, vol.89
, pp. 1255-1263
-
-
Qi, Z.1
Takamatsu, H.2
Espinoza, J.L.3
-
31
-
-
78650316570
-
Immunosuppresive therapies in the management of immune-mediated marrow failures in adults: Where we stand and where we are going
-
Risitano AM (2011) Immunosuppresive therapies in the management of immune-mediated marrow failures in adults: where we stand and where we are going. Br J Haematol 152:127-140
-
(2011)
Br J Haematol
, vol.152
, pp. 127-140
-
-
Risitano, A.M.1
-
32
-
-
3242782610
-
In-vivo dominant immune responses in aplastic anaemia: Molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing
-
DOI 10.1016/S0140-6736(04)16724-X, PII S014067360416724X
-
Risitano AM, Maciejewski J, Green S et al (2004) In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet 364:355-364 (Pubitemid 38970012)
-
(2004)
Lancet
, vol.364
, Issue.9431
, pp. 355-364
-
-
Risitano, A.M.1
Maciejewski, J.P.2
Green, S.3
Plasilova, M.4
Zeng, W.5
Young, N.S.6
-
33
-
-
76449093834
-
Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anemia and single-lineage bone marrow failure: A pilot study and a survey from the EBMT WPSSAA
-
Risitano AM, Selleri C, Serio B et al (2010) Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anemia and single-lineage bone marrow failure: a pilot study and a survey from the EBMT WPSSAA. Br J Haematol 148:791-796
-
(2010)
Br J Haematol
, vol.148
, pp. 791-796
-
-
Risitano, A.M.1
Selleri, C.2
Serio, B.3
-
34
-
-
0037420270
-
Antithymocyte Globulin and Cyclosporine for Severe Aplastic Anemia: Association between Hematologic Response and Long-term Outcome
-
DOI 10.1001/jama.289.9.1130
-
Rosenfeld S, Follmann D, Nunez O et al (2003) Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematopoietic response and long term outcome. JAMA 289:1130-1135 (Pubitemid 37430327)
-
(2003)
Journal of the American Medical Association
, vol.289
, Issue.9
, pp. 1130-1135
-
-
Rosenfeld, S.1
Follmann, D.2
Nunez, O.3
Young, N.S.4
-
35
-
-
84858699080
-
Hipoplasias y displasias medulares
-
Ruiz-Argüelles GJ (ed) 4th edn. Editorial Médica Panamericana, México
-
Ruiz-Argüelles GJ (2009) Hipoplasias y displasias medulares. In: Ruiz-Argüelles GJ (ed) Fundamentos de Hematología, 4th edn. Editorial Médica Panamericana, México, pp 117-127
-
(2009)
Fundamentos de Hematología
, pp. 117-127
-
-
Ruiz-Argüelles, G.J.1
-
37
-
-
66349094784
-
Making allogeneic bone marrow transplantation available to patients in developing countries: The Mexican Experience
-
Ruiz-Argüelles GJ, Gómez-Almaguer D (2008) Making allogeneic bone marrow transplantation available to patients in developing countries: the Mexican Experience. Open Hematol J 2:30-36
-
(2008)
Open Hematol J
, vol.2
, pp. 30-36
-
-
Ruiz-Argüelles, G.J.1
Gómez-Almaguer, D.2
-
38
-
-
0345168165
-
Long term results of the immunosuppressive treatment of patients with severe, acquired aplastic anemia: A single institution study
-
Ruiz-Argüelles GJ, Gómez-Rangel D (2003) Long term results of the immunosuppressive treatment of patients with severe, acquired aplastic anemia: a single institution study. Acta Haematol 110:184-187
-
(2003)
Acta Haematol
, vol.110
, pp. 184-187
-
-
Ruiz-Argüelles, G.J.1
Gómez-Rangel, D.2
-
40
-
-
0022755650
-
Preparation and characteristics of an equine anti-human thymocyte gamma globulin produced in Mexico
-
in Spanish
-
Ruiz-Argüelles A, Salvador Ruiz-González JD, Miguel Presno-Bernal J (1986) Preparation and characteristics of an equine anti-human thymocyte gamma globulin produced in Mexico (in Spanish). Rev Invest Clin 38:273-278
-
(1986)
Rev Invest Clin
, vol.38
, pp. 273-278
-
-
Ruiz-Argüelles, A.1
Salvador Ruiz-González, J.D.2
Miguel Presno-Bernal, J.3
-
41
-
-
37249068118
-
Cyclosporin A response and dependence in children with acquired aplastic anaemia: A multicentre retrospective study with long-term observation follow-up
-
DOI 10.1111/j.1365-2141.2007.06903.x
-
Saracco P, Quarelli P, Iori AP et al (2008) Cyclosporin A response and dependence in children with acquired aplastic anemia: a multicentre retrospective study with long-term observation follow-up. Br J Haematol 140:197-205 (Pubitemid 350265046)
-
(2008)
British Journal of Haematology
, vol.140
, Issue.2
, pp. 197-205
-
-
Saracco, P.1
Quarello, P.2
Iori, A.P.3
Zecca, M.4
Longoni, D.5
Svahn, J.6
Varotto, S.7
Del, V.G.C.8
Dufour, C.9
Ramenghi, U.10
Bacigalupo, A.11
Locasciulli, A.12
-
42
-
-
33646688643
-
Treatment of severe aplastic anaemia with combined immunosuppression: Anti-thymocyte globulin, ciclosporin and mycophenolate mofetil
-
DOI 10.1111/j.1365-2141.2006.06085.x
-
Scheinberg P, Nuñez O, Wu C et al (2006) Treatment of severe aplastic anaemia with combined immunosuppression: anthytimocyte globulin, cyclosporine and mycophenolate mofetil. Br J Haematol 133:606-611 (Pubitemid 43742774)
-
(2006)
British Journal of Haematology
, vol.133
, Issue.6
, pp. 606-611
-
-
Scheinberg, P.1
Nunez, O.2
Wu, C.3
Young, N.S.4
-
43
-
-
62949210719
-
Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with and without sirolimus, a prospective randomized study
-
Scheinberg P, Wu CO, Nuñez O et al (2009a) Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with and without sirolimus, a prospective randomized study. Haematologica 94:348-354
-
(2009)
Haematologica
, vol.94
, pp. 348-354
-
-
Scheinberg, P.1
Wu, C.O.2
Nuñez, O.3
-
44
-
-
58149090759
-
Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia
-
Scheinberg P, Wu CO, Nuñez O et al (2009b) Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol 144:206-216
-
(2009)
Br J Haematol
, vol.144
, pp. 206-216
-
-
Scheinberg, P.1
Wu, C.O.2
Nuñez, O.3
-
45
-
-
79959479873
-
A randomized trial of horse versus rabbit antithymocyte globulin in severe acquired aplastic anemia
-
Scheinberg P, Wu CO, Scheinberg P et al (2010a) A randomized trial of horse versus rabbit antithymocyte globulin in severe acquired aplastic anemia. Blood 116:a4
-
(2010)
Blood
, vol.116
-
-
Scheinberg, P.1
Wu, C.O.2
Scheinberg, P.3
-
46
-
-
79961102745
-
Alemtuzumab (Campath)monotherapy for severe aplastic anemia
-
Scheinberg P, Wu CO, Scheinberg P et al (2010b) Alemtuzumab (Campath)monotherapy for severe aplastic anemia. Blood 116:a1167
-
(2010)
Blood
, vol.116
-
-
Scheinberg, P.1
Wu, C.O.2
Scheinberg, P.3
-
47
-
-
79959418648
-
Novel immunosuppressive strategies for bone marrow failure syndromes: A focus on Alemtuzumab
-
Selleri C, Serio B, Risitano AM (2011) Novel immunosuppressive strategies for bone marrow failure syndromes: a focus on Alemtuzumab. Mini Rev Med Chem 11:536-543
-
(2011)
Mini Rev Med Chem
, vol.11
, pp. 536-543
-
-
Selleri, C.1
Serio, B.2
Risitano, A.M.3
-
48
-
-
79958063092
-
Costs and consequences of immunosuppressive therapy in children with aplastic anemia
-
Shereck EB, Deyell RJ, Kurre P (2011) Costs and consequences of immunosuppressive therapy in children with aplastic anemia. Haematologica 96:793-795
-
(2011)
Haematologica
, vol.96
, pp. 793-795
-
-
Shereck, E.B.1
Deyell, R.J.2
Kurre, P.3
-
49
-
-
0035525528
-
From T to B and back again: Positive feedback in systemic autoimmune disease
-
Shlomchik MJ, Craft JE, Mamula MJ (2001) From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 1:147-153 (Pubitemid 33741968)
-
(2001)
Nature Reviews Immunology
, vol.1
, Issue.2
, pp. 147-153
-
-
Shlomchik, M.J.1
Craft, J.E.2
Mamula, M.J.3
-
50
-
-
78650354414
-
Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remission
-
Sloand EM, Olnes MJ, Shenoy A et al (2010a) Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remission. J Clin Oncol 28:5166-5173
-
(2010)
J Clin Oncol
, vol.28
, pp. 5166-5173
-
-
Sloand, E.M.1
Olnes, M.J.2
Shenoy, A.3
-
51
-
-
77949707207
-
Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab
-
Sloand EM, Olnes MJ, Weinstein B et al (2010b) Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab. Haematologica 95:382-387
-
(2010)
Haematologica
, vol.95
, pp. 382-387
-
-
Sloand, E.M.1
Olnes, M.J.2
Weinstein, B.3
-
52
-
-
0017738691
-
Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions
-
Speck B, Gluckman E, Haak HL et al (1977) Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions. Lancet 2:1145-1148 (Pubitemid 8231994)
-
(1977)
Lancet
, vol.2
, Issue.8049
, pp. 1145-1148
-
-
Speck, B.1
Gluckman, E.2
Haak, H.L.3
Van Rood, J.J.4
-
53
-
-
77950327120
-
Rituximab in autoimmune hematologic diseases: Not just a matter of B cells
-
Stasi R (2010) Rituximab in autoimmune hematologic diseases: not just a matter of B cells. Semin Hematol 47:170-179
-
(2010)
Semin Hematol
, vol.47
, pp. 170-179
-
-
Stasi, R.1
-
54
-
-
0141792797
-
Persistent remission after immunosuppressive therapy of hairy cell leukemia mimicking aplastic anemia: Two case reports
-
Sugimori C, Kaito K, Nakao S (2003) Persistent remission after immunosuppressive therapy of hairy cell leukemia mimicking aplastic anemia: two case reports. Int J Hematol 77:391-394 (Pubitemid 37121838)
-
(2003)
International Journal of Hematology
, vol.77
, Issue.4
, pp. 391-394
-
-
Sugimori, C.1
Kaito, K.2
Nakao, S.3
-
55
-
-
79956034345
-
Aplastic anemia successfully treated with rituximab: The possible role of aplastic anemia-associated autoantibodies as a marker for response
-
Takamatsu H, Yagasaki H, Takahashi Y et al (2011) Aplastic anemia successfully treated with rituximab: the possible role of aplastic anemia-associated autoantibodies as a marker for response. Eur J Haematol 86:541-545
-
(2011)
Eur J Haematol
, vol.86
, pp. 541-545
-
-
Takamatsu, H.1
Yagasaki, H.2
Takahashi, Y.3
-
56
-
-
84920231225
-
Aplastic anemia treated by marrow transplantation
-
Thomas ED, Storb R, Fefer A et al (1972) Aplastic anemia treated by marrow transplantation. Lancet 1:284-289
-
(1972)
Lancet
, vol.1
, pp. 284-289
-
-
Thomas, E.D.1
Storb, R.2
Fefer, A.3
-
57
-
-
78650382800
-
Comparison between lymphoglobulin- and thymoglobulin-based immunosuppressive therapy as first-line treatment for patients with aplastic anemia
-
Vallejo C, Montesinos P, Rosell A et al (2009) Comparison between lymphoglobulin- and thymoglobulin-based immunosuppressive therapy as first-line treatment for patients with aplastic anemia. Blood 114:a3194
-
(2009)
Blood
, vol.114
-
-
Vallejo, C.1
Montesinos, P.2
Rosell, A.3
-
58
-
-
0034786378
-
The effect of treatment with Campath-1H in patients with autoimmune cytopenias
-
DOI 10.1046/j.1365-2141.2001.03039.x
-
Willis F, Marsh JC, Bevan DH et al (2001) The effect of treatment with Campath-1H in patients with autoimmune cytopenias. Br J Haematol 114:891-898 (Pubitemid 32953751)
-
(2001)
British Journal of Haematology
, vol.114
, Issue.4
, pp. 891-898
-
-
Willis, F.1
Marsh, J.C.W.2
Bevan, D.H.3
Killick, S.B.4
Lucas, G.5
Griffiths, R.6
Ouwehand, W.7
Hale, G.8
Waldmann, H.9
Gordon-Smith, E.C.10
-
59
-
-
0011437539
-
Acquired aplastic anemia
-
Schechter GP, Berliner N, Telen MJ (eds) The American Society of Hematology Education Program Book, Washington
-
Young NS (2000) Acquired aplastic anemia. In: Schechter GP, Berliner N, Telen MJ (eds) Hematology 2000. The American Society of Hematology Education Program Book, Washington, pp 18-38
-
(2000)
Hematology 2000
, pp. 18-38
-
-
Young, N.S.1
-
60
-
-
0030912049
-
The pathophysiology of acquired aplastic anemia
-
DOI 10.1056/NEJM199705083361906
-
Young NS, Maciejewski JP (1997) The pathophysiology of acquired aplastic anemia. N Engl J Med 336:1365-1372 (Pubitemid 27208621)
-
(1997)
New England Journal of Medicine
, vol.336
, Issue.19
, pp. 1365-1372
-
-
Young, N.S.1
Maciejewski, J.2
-
61
-
-
33745438684
-
Immunosuppressive therapy for acquired severe aplastic anemia (SAA): A prospective comparison of four different regimens
-
DOI 10.1016/j.exphem.2006.03.017, PII S0301472X06002384
-
Zheng Y, Liu Y, Chu Y et al (2006) Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens. Exp Hematol 34:826-831 (Pubitemid 43949184)
-
(2006)
Experimental Hematology
, vol.34
, Issue.7
, pp. 826-831
-
-
Zheng, Y.1
Liu, Y.2
Chu, Y.3
-
62
-
-
0022006029
-
Circulating activated suppressor T lymphocytes in aplastic anemia
-
Zoumbos NC, Gascón P, Djeu JY et al (1985) Circulating activated suppressor T lymphocytes in Aplastic anemia. N Engl J Med 312:257-265 (Pubitemid 15199363)
-
(1985)
New England Journal of Medicine
, vol.312
, Issue.5
, pp. 257-265
-
-
Zoumbos, N.C.1
Gascon, P.2
Djeu, J.Y.3
|